Oct 7, 2020
KitovPharma Ltd. (“Kitov”) (NASDAQ: KTOV), a leading clinical step firm in the area of tumor preventive therapy and resilience, has today announced that the firm has entered a final stage with some medical-care regulatory speculators for the procurement...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT Privacy & Cookies Policy
